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eart transplantation (HT) is an established life-saving treatment option for patients with end-stage heart
ailure. Despite many advances in the field, the development of acute cellular rejection (ACR) and cardiac
llograft vasculopathy (CAV) represent significant causesof 1- and5-yearmorbidity andmortality, respectively.
he search for noninvasive techniques to assess cardiac allograft function and detect treatable ACR and CAV
emains a priority objective for heart transplant professionals. In this review we will: 1) highlight the clinical
ignificance of ACR and CAV in adult cardiac transplant recipients and 2) discuss how different noninvasive
maging modalities (echocardiography, cardiac computed tomography, myocardial perfusion imaging, and
ardiacmagnetic resonance)havebeenused in theevaluationof theseclinical challengesafterHT. (JAmColl
ardiol Img 2009;2:1126–40) © 2009 by the American College of Cardiology Foundationo
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He
n, Teart transplantation (HT) is an established
ife-saving treatment option for patients with
nd-stage heart failure. Despite many advances
n the field, the development of acute cellular
ejection (ACR) and cardiac allograft vascu-
opathy (CAV) represent significant causes of
orbidity and mortality (1). Historically, sur-
eillance for ACR and CAV has been based on
nvasive procedures, which carry inherent risks
nd high costs. The search for noninvasive
echniques to assess allograft function and
etect treatable ACR and CAV remains a
riority objective for heart transplant profes-
ionals. Noninvasive imaging techniques used
n this regard include transthoracic echocardi-
graphy, multidetector computed tomography
MDCT), single-photon emission computed
omography-myocardial perfusion imaging
SPECT-MPI), and cardiac magnetic reso-
ance (CMR). The ideal test for the detection
rom the Department of Cardiology, Section of Heart Failure and
nstitute, Methodist DeBakey Heart and Vascular Center, Houstoanuscript received April 9, 2009; revised manuscript received June 1f ACR and CAV should be highly sensitive
nd specific, able to evaluate changes before
nd after treatment, noninvasive with high
eproducibility, and associated with low cost
nd favorable outcome. In this review, we will:
) highlight the clinical significance of ACR
nd CAV in adult cardiac transplant recipients;
nd 2) discuss how different noninvasive imag-
ng modalities have been used in the evaluation
f these clinical challenges after HT.
CR
linical signiﬁcance. In ACR, effector T cells
ediate an inflammatory response that leads to
yocardial edema and myocyte damage. Rou-
ine surveillance of ACR is currently performed
ith endomyocardial biopsy (EMB) and is
ssociated with good clinical results. The cur-
ent management strategy depends on the his-
art Transplantation, and Cardiovascular Imaging
exas.9, 2009, accepted June 24, 2009.
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1127ologic type and grade of rejection and the presence
r absence of hemodynamic compromise (decreased
llograft systolic function and/or hemodynamic in-
tability). Using the International Society of Heart
nd Lung Transplantation revised grading system,
MB grade 2R (previously 3A) or higher rejection
s considered clinically significant and prompts the
se of high-dose corticosteroids and possibly the
se of lymphocyte-depleting agents in patients with
emodynamic compromise.
Although EMB is considered the gold standard
or the diagnosis of ACR, its value may be limited
y sampling error, interobserver variability, and
ide variability in the frequency and duration of its
se as surveillance among transplant centers. Several
oninvasive imaging techniques (clinically accepted
nd investigational) have been performed to detect
CR at different stages in the disease process (Fig. 1).
ith current advances in immunosuppression, the
ajority of patients who develop ACR have no
ignificant changes in left ventricular (LV) ejection
raction regardless of the imaging modality used
2–4). However, monitoring cardiac allograft sys-
olic function is important in suspected or proven
CR because more aggressive immunosuppression
an lead to improvement in LV function in patients
ith depressed function.
chocardiography and ACR. CONVENTIONAL ECHO-
ARDIOGRAPHY. Although wall thickness and LV
ass measured by M-mode and 2-dimensional
chocardiography have been shown to increase dur-
ng ACR episodes (5), ACR-induced myocardial
dema may manifest by subtle changes in relative
all thickness, accounting in part for the conflicting
esults on the usefulness of these echocardiography
arameters to detect ACR (6–8). Investigators
ave also noted that the presence of a pericardial
ffusion in cardiac transplant recipients is associated
ith a higher incidence of ACR (9). Pericardial
ffusion, however, occurs frequently in the post-
perative period, hence its low sensitivity (49%)
nd specificity (74%) to detect ACR (10).
PECTRAL DOPPLER IMAGING. Early investigations
emonstrated altered LV diastolic twist mechanics
n the absence of systolic dysfunction to suggest that
iastolic dysfunction precedes systolic abnormalities
n patients with ACR (11). Multiple studies have
lso evaluated LV Doppler inflow indexes to detect
CR, including early diastolic (E) peak velocity,
ate diastolic (A) peak velocity, E/A ratio, E-wave
ressure half time (PHT), and isovolumic relax-
tion time (IVRT) (12,13). Standard transmitral
oppler-derived indexes in cardiac transplant re- eipients have had limitations in predicting ACR;
hese limitations relate to the influence of several
arameters on these indexes including donor age,
eart rate (which may be variable in the setting of
ardiac denervation), loading conditions, and the
issociation between the electrical activity of 2 atria
especially important with the biatrial anastomosis
echnique when evaluating older studies). Mena et
l. (12) performed a systematic review of the pub-
ished literature between 1967 and 2005 and re-
orted that the majority of studies that examined
he change in the mitral E and A peak velocities
ver time did not predict ACR and the correlation
etween ACR and PHT and IVRT was not con-
istent (sensitivity and specificity range for PHT
3% to 87% and 76% to 98%; IVRT 28%
o 85% and 80% to 98%, respectively)
12). The discordance in the literature may
e in part related to significant interpa-
ient and intrapatient variability and the
ependence of these indexes on multiple
actors in addition to ACR (8). In addi-
ion to transmitral Doppler indexes, sev-
ral studies have examined changes in
ulmonary vein flow indexes (8,10,14),
V diastolic flow propagation (8,15), and
he myocardial performance index (16,17)
o detect ACR—with conflicting results.
ISSUE DOPPLER IMAGING (TDI). More
ecently, the use of TDI to detect ACR has
een investigated, with improved results.
nvestigators from Berlin, Germany, using
ulsed wave–TDI obtained from the basal
osterior wall, have demonstrated that a
eduction in peak systolic radial velocity
Sm) and peak early diastolic velocity (Em
also known as Ea]) is helpful in detecting
ardiac rejection (sensitivity and specificity
or Sm reduction10%,87% and94%; sensitivity
nd specificity for Em reduction 10%, 90% and
6%, respectively) (3,18). These investigators have
lso reported on the value of serial TDI screening
ased on the high negative and positive predictive
alues of changes in diastolic parameters (i.e., 10%
m reduction) for ACR to guide the effective use of
MBs (19). In contrast, with the mitral valve annulus
sed as the site for analysis, some studies have found
ignificant decreases in systolic velocities with ACR
8,20), whereas other investigators have not (15).
iscordant results have also been seen by color Dopp-
er or conventional TDI (12,20). These discrepancies
ith regard to the clinical usefulness of these param-
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1128ome studies using pulsed wave versus color TDI and
sing tissue Doppler Ea from different myocardial
alls or mitral valve annulus locations (3,14,15,20).
inally, the E/Ea ratio—a validated parameter for
stimation of LV filling pressure in the transplanted
eart (21) (Fig. 2)—has been evaluated by 2 different
roups to detect ACR, with conflicting results
10,14). The clinical usefulness of this TDI-derived
ndex to detect ACR remains unclear given that
aradoxical septal motion is noted often in cardiac
ransplant recipients and in the current era of immu-
osuppression, patients with ACR are often asymp-
omatic with normal ventricular filling pressure.
ROMISING ECHOCARDIOGRAPHIC TECHNIQUES.
ovel echocardiographic techniques have been re-
ently developed and have been applied to the
valuation of ACR. These include strain and strain
ate imaging (22) (Fig. 3), 2-dimensional derived
ntegrated backscatter (6), automated border detec-
ion with acoustic quantification to measure LV
eak filling rate (23), and color Doppler imaging to
easure late isovolumic relaxation myocardial ve-
ocity gradients and early diastolic timing interval
ifferences (14) (Table 1). These quantitative echo-
ardiographic techniques of regional and global
yocardial function show promise to identify sub-
linical LV dysfunction in a small number of cardiac
ransplant recipients and need further validation in
arger studies.
MR and ACR. Although many transplant centers
se echocardiography to detect cardiac allograft
CMR*
*
*
Echocardiography
Immune-Mediated 
Cardiac Allograft Injury
Myocardial Mononuclear 
Cell Infiltration
Myocardial Necrosis
and Edema 
Cardiac Allograft 
Diastolic Dysfunction
Figure 1. Different Noninvasive Imaging Techniques Performed
Cellular Rejection
ACR  acute cellular rejection; CMR  cardiac magnetic resonance
and Lung Transplantation.ystolic dysfunction in the setting of cardiac rejec- pion, CMR enables imaging throughout the cardiac
ycle and provides excellent spatial resolution to
ccurately measure diastolic and systolic volumes
nd hence left and right ventricular ejection frac-
ions (24) (Fig. 4). CMR may also be useful in the
etection of ACR by its ability to quantitate
hanges in myocardial mass (25) or more specifi-
ally to detect myocardial edema. The latter is
ccomplished by measurement of myocardial T2
alues, which are elevated in the setting of increased
yocardial water content. Marie et al. (26) demon-
trated in 68 cardiac transplant recipients that a
igher than normal T2 value (56 ms) was suffi-
iently accurate (sensitivity 89%; specificity 70%) to
etect ACR defined by EMB (grade 2R). An
bnormal T2 value was also a strong predictor of
ubsequent biopsy-defined ACR, suggesting early
etection of ACR. Although promising, this inves-
igation involved a select cohort of patients with
uspected rejection on the basis of clinical or echo-
ardiographic data; therefore, the true sensitivity
nd specificity of this method to detect ACR in
nselected cohorts is currently unknown and needs
urther evaluation.
With the administration of a paramagnetic con-
rast medium, gadolinium, CMR studies have also
een used to detect inflammatory changes in the
yocardium. Almenar et al. (2), using gadolinium-
iethylene triamine pentaacetic acid-enhanced
MR in 40 cardiac transplant recipients, showed an
ncrease in relative myocardial contrast uptake in
Clinically Accepted
Investigational*
*
Cardiac Allograft
Systolic Dysfunction
ISHLT Biopsy Grading (2004)
Grade 0R No ACR
Grade 1R Mild, Low-grade
Grade 2R Moderate, Intermediate
Grade 3R Severe, High-grade
*
*
*
*
Echocardiography
Scintigraphy 
CMR   and 
Cardiac CT
arious Stages of Cardiac Involvement to Detect Acute
 computed tomography; ISHLT  International Society of Heartat V
; CTatients with necrosis on EMB compared with
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1129hose without necrosis. Although their series re-
uired extensive image analysis to compute changes
n signal intensity in various tissues (heart and
ectoralis muscle) before and after administration
f contrast, our experience has shown that the use
f traditional delayed enhancement CMR may also
emonstrate areas of hyperenhancement in the
etting of ACR. These areas appear to diminish
fter treatment of the ACR episode (Fig. 5). In
eneral, CMR studies have been limited by small
ample size with few confirmatory validations. In
ddition, gadolinium use in patients with acute or
hronic severe renal insufficiency (estimated glo-
erular filtration rate 30 ml/min) carries a sig-
ificant risk for development of nephrogenic sys-
emic fibrosis. Because of these drawbacks and the
ack of widespread availability, the role of CMR in
valuation of ACR is still evolving.
AV
linical signiﬁcance. Cardiac allograft vasculopathy,
revalent in approximately 54% of survivors 10
ears after HT, is characterized by diffuse intimal
yperplasia that is likely the result of cumulative
ndothelial injuries (1,27). The early diagnosis of
AV is challenging because typical clinical symp-
oms of ischemia are lacking, given cardiac dener-
ation and the fact that coronary angiography can
nderestimate the severity of disease. Early recog-
ition is important because rapid CAV progression,
s defined by intravascular ultrasound (IVUS), has
een shown to be a powerful predictor of all-cause
ortality and myocardial infarction (27). Although
VUS is considered the most sensitive tool to detect
AV, coronary angiography is still the standard in
any transplant centers.
Treatment of CAV focuses on the use of prolif-
ration signal inhibitors to decrease progression,
tatin therapy for long-term survival benefit, anti-
latelet therapy, and percutaneous revasculariza-
ion, although the benefit may be limited because of
he diffuse nature of the disease (27). Given the
rawbacks of the invasive nature and high cost of
oth IVUS and coronary angiography, a noninva-
ive imaging modality is needed to identify patients
t risk for CAV. Several imaging modalities (clin-
cally accepted and investigational) have been used
or the detection of CAV at various stages in the
isease process (Fig. 6).
chocardiography and CAV. REST CONVENTIONAL
CHOCARDIOGRAPHY AND TDI. Resting wall mo-
ion abnormalities as detected by 2-dimensionalFigure 2. Noninvasive Detection of Elevated Left Ventricular Filling Pressure in
Cardiac Transplant Recipients Using Doppler Echocardiography
(A) Pulsed Doppler recording of the mitral ﬂow velocity and the corresponding annular velocities
by tissue Doppler at the time of ﬁrst right-sided cardiac catheterization. (B) Pulsed Doppler of
mitral inﬂow and the corresponding tissue Doppler velocities at the time of the repeat right-
sided cardiac catheterization (4 weeks later). Mean measured pulmonary capillary wedge pres-
sure (PCWP) decreased from 24 to 11 mm Hg. The E/Ea ratio decreased from 15 to 5, predicting
a decrease in estimated wedge pressure from 24 to 9 mm Hg (PCWP  2.6  1.46 [E/Ea]). E 
peak mitral inﬂow velocity; Ea  peak mitral annular velocity; MV  mitral valve.
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1130chocardiography derived from 12 different studies
re in general associated with low sensitivities
47%; range 12% to 80%) but high specificity for
he presence of CAV (84%; range 69% to 100%),
upporting the notion that this finding should
rompt further testing to exclude CAV (13). A few
tudies have examined resting TDI to detect CAV
18,28). After excluding ACR, Hummel et al. (18)
eported that pulse wave TDI-derived radial peak
ystolic velocity (Sm value 10 cm/s) was associ-
ted with a 97% likelihood for CAV, whereas Sm
alues 11 cm/s excluded accelerated CAV with
0% probability. This group of investigators also
al Strain Derived From the Speckle-Tracking Technique
(38%), peak 47%, obtained from the parasternal short axis view
st-heart transplantation (biopsy grade 2R performed on the same
in the global radial strain (58%), peak 68%, 2 weeks later after
nosuppression (biopsy grade 1R). ACR  acute cellular rejection;
sure.emonstrated that serial TDI can potentially spare tatients unnecessary routine invasive examinations
28). These are promising results that need further
alidation but may point to advanced CAV, affect-
ng myocardial properties at rest.
TRESS ECHOCARDIOGRAPHY. Stress echocardiog-
aphy using exercise, dipyridamole, and dobutamine
as been evaluated to detect CAV (Table 2). The
lunted heart rate response to exercise because of
ardiac denervation limits the sensitivity (range 15%
o 33%) of exercise testing to detect CAV (29–31).
n contrast, the use of pharmacologic stress testing
dipyridamole and dobutamine) to detect CAV has
een shown to be more sensitive (85%; range 50%
o 100%) (32–43). The variable specificity (range
1% to 95%) of dobutamine stress echocardiogra-
hy (DSE) is likely a reflection of the differences in
efining the presence and severity of CAV by
oronary angiography. When compared with
VUS—a more sensitive gold standard—the speci-
city of DSE for CAV is higher (83% to 88%)
42,43). In comparison, Eroglu et al. (40) demon-
trated that quantitative DSE using strain rate
maging detects CAV accurately regardless of the
ngiographic significance and that a post-systolic
train index 34% at peak stress was the best
arameter.
ROGNOSTIC VALUE OF ECHOCARDIOGRAPHY. The
linical usefulness of noninvasive imaging in
AV relates also to the test’s prognostic value
Table 3). Several investigators have demon-
trated the impact of resting wall motion abnor-
alities and DSE findings on major adverse
ardiac events (MACE) after HT, including
eart failure, unstable angina, myocardial infarc-
ion, revascularization, retransplantation, and
ardiac death (32–37,42,44–48). The majority of
tudies were performed more than 3 years after
T, with a follow-up on average of 3 years.
he negative predictive value of a normal DSE
as very high (3% risk of experiencing MACE
ver the ensuing year). As demonstrated by Spes
t al. (42), serial DSE may best prognosticate
ased on the finding that worsening DSE results
ere as predictive of subsequent events as serial
oronary angiography or IVUS. Based on these
verall results, annual evaluation with DSE is an
cceptable alternative to invasive means for de-
ection of CAV in transplant centers experienced
n stress echocardiography.
ROMISING ECHOCARDIOGRAPHIC TECHNIQUES.
ontrast-enhanced echocardiography is a recentFigure 3. Global Radi
(A) Global radial strain
in a patient 1 week po
day). (B) Improvement
enhancement in immuechnique that allows quantification of coronary
fl
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1131ow reserve and/or myocardial perfusion mismatch
o detect significant coronary artery disease. Prelim-
nary studies in cardiac transplant recipients using
tress echocardiography with contrast (49,50) show
elatively high accuracy (85% to 89%) to detect
AV (Table 2). Moreover, Tona et al. (51) have
emonstrated the validity of a lower coronary flow
elocity pattern and flow reserve with contrast
chocardiography as noninvasive markers of CAV-
elated MACE. These results, however, are based
Table 1. Studies Evaluating the Accuracy of Different Echocardi
Author, Year (Ref. #)
Total Patients
(Prevalence of ACR)
Angermann et al., 1997 (6) 52 (18%*) Integrate
(PW 2D-
(Septal 2
Puleo et al., 1998 (15) 121 (13%) PW-TDI
(Ea of in
Mankad et al., 1999 (20) 78 (18%) Color-co
(combin
diasto
(posterio
time-g
Moidl et al., 1999 (23) 94 (20%) Automat
(peak ﬁll
(peak ﬁll
18%
Stengel et al., 2001 (8) 41 (39%) PW-TDI
(Aa of la
Dandel et al., 2002 (3) 190 (17%*) PW-TDI
(Sm of b
(Ea of ba
Palka et al., 2005 (14) 44 (27%) PW and
(Ea of se
(peak lat
(onset E
(onset ET
Sun et al., 2005 (10) 2-D and standard Doppler Grade 
(2 amo
223 (37%*) Post-HT
183 (27%*) Post-HT
264 (29%*) PW-TDI
(Aa of se
Marciniak et al., 2007 (22) 31 (32%) Color TD
(mid-LVP
(mid-LVP
*Prevalence of ACR based on the percentage of biopsies with ACR deﬁned by t
clinical symptoms. ‡Peak late isovolumic relaxation myocardial velocity gradient
and early diastolic septal MV annulus velocity (EMed). Timing difference betw
velocity (EMitr).
Aa  peak late diastolic velocity; ACR  acute cellular rejection; dB  decibe
transplantation; IVRT  isovolumic relaxation time; LVPW  left ventricular pos
wave 2-dimensional-integrated backscatter; Sm  peak radial systolic velocity;n a small number of patients, and further valida- aion studies are warranted before widespread adop-
ion can be advocated.
PI and CAV. MPI DIAGNOSTIC VALUE. Similar to
SE, several studies have examined MPI using exer-
ise, dipyridamole, and dobutamine to detect CAV
Table 2). The overall sensitivity and specificity range
fMPI to detect CAV is broad (21% to 92% and 55%
o 100%, respectively) (45,46,52–56). This variability
ay be explained by differences in the timing of the
xaminations, the stressors and/or MPI agents used,
phy Techniques to Detect Acute Cellular Rejection
Method
rameter Cutoff Value)
Gold Standard
(EMB Score) Sensitivity
ackscatter Grade 1B
crease 1.5 dB) 88%
increase 1.5 dB) 83%
Grade 3A
r wall 16 cm/s) 76%
TDI Grade 1B
eak MV systolic and peak
elocity 135 mm/s)
93%
ll tissue Doppler diastolic
ient integral 0.26)
91%
order detection Grade 2
rate 4.0 EDV/s) 100%
rate 4.0 EDV/s and
uction)
100%
Grade 3A
l MV annulus 8.7 cm/s) 82%
Clinically relevant†
posterior wall reduction 10%) 88%
posterior wall reduction 10%) 89%
r M-mode TDI Grade 3A
MV annulus 12 cm/s) 69%
R MVG‡ 0.1/s) 88%
e –onset Emed§ 35 ms) 81%
–onset EMitr 15 ms) 81%
PE, IVRT 90 ms E/A 1.7)
months 57%
months 60%
/lateral MV annulus 9.0 cm/s) 67%
Grade 1B
adial peak systolic strain 30%) 85%
adial peak systolic SR 3.0 s-1) 80%
MB score. †Clinically relevant ACR deﬁned as EMB grade 2 plus grades 1A and 1
e left ventricular posterior wall. §Timing difference between onset of mitral early
nset of early diastolic velocity at lateral tricuspid (ETric) annulus and LV early di
 peak early diastolic velocity; EDV  end diastolic volume; EMB  endomyoc
r wall; MV  mitral valve; NPV  negative predictive value; PE  pericardial effu
strain rate; TDI  tissue Doppler imaging.ogra
(Pa Speciﬁcity NPV
d b
IB in 89% 97%
D-IB 85% 96%
ferio 88% 96%
ded
ed p
lic v
71% 98%
r wa
rad
61% 97%
ed b
ing 70% 100%
ing
red
95% 100%
tera 53% 82%
asal 95% 97%
sal 97% 98%
colo
ptal 46% 80%
e IV 58% 93%
wav 84% 92%
ric 84% 92%
1B
ng
6 54% 68%
6 93% 86%
ptal 49% 78%
I
W r 90% 93%
W r 86% 90%
he E B when accompanied by
of th diastolic velocity (E wave)
een o astolic lateral MV annulus
ls; Ea ardial biopsy; HT  heart
terio sion; PW 2D-IB  pulsed
SR nd the variable criteria used to diagnosis CAV.
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1132imilar to the DSE literature, the sensitivity to detect
AV overall increases with the inclusion of studies that
efine CAV as coronary stenosis 50% (45,54,57). In
ddition, early studies were performed using thallium,
hich may encounter more attenuation artifacts than
echnetium-labeled radiopharmaceuticals and may ac-
ount for the reported reduced accuracy compared with
ore recent studies (sensitivity 86% and specificity
80%) using technetium-labeled agents (46,52–54).
Compared with exercise and dipyridamole, dobut-
mine has been reported to be advantageous as a
tressor because of its more reliable induction of
schemia in cardiac transplant recipients (inotropic
ffect, less blunted heart rate response). Moreover, the
se of vasodilators withMPImay be limited in cardiac
ransplant recipients because the diffuse, microvascular
AV may impair the necessary increase in coronary
ow reserve to trigger the flow heterogeneity to detect
ignificant stenosis. Despite these observations, more
A
B
Figure 4. CMR Assessment of Left and Right Ventricular Systolic F
Cardiac Rejection
(A) Pre-treatment biventricular dysfunction with a large thrombus in
there was substantial improvement in biventricular function, and th
therapy. Full-motion cine images can be viewed online. LVEF  left
fraction.ecent studies using dipyridamole MPI have demon-trated comparable sensitivity (range 80% to 92%) and
pecificity (range 86% to 92%) to dobutamine stress
PI to detect CAV (46,52–54).
PI PROGNOSTIC VALUE. Similar to DSE, the po-
ential clinical usefulness of SPECT-MPI relates to
ts prognostic value. Although exercise testing
inked with echocardiography and MPI is associ-
ted with low sensitivity to detect CAV, investiga-
ors have demonstrated that a normal exercise MPI
t 1 year is a significant predictor of 1- and 5-year
urvival (45,48). Elhendy et al. (58) reported on 65
atients who underwent symptom-limited bicycle
xercise with technetium-99m tetrofosmin MPI
nd demonstrated a similar ability to predict cardiac
eath in comparison with dobutamine. In contrast
o these studies, Bacal et al. (34) reported that
hallium scintigraphy with treadmill testing in a
maller number of patients was not an independent
redictor of long-term 4-year survival.
tion Pre- and Post-Treatment of an Episode of
e right ventricular apex (arrow). (B) Two weeks post-treatment
rombus appears to have decreased in size with anticoagulation
tricular ejection fraction; RVEF  right ventricular ejectionunc
th
e th
venSimilar to the overall results of exercise MPI,
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1133harmacologic stress MPI also has significant
rognostic value (Table 3). Two different inves-
igators demonstrated that a normal dobutamine
tress MPI study was associated with a 96%
o 98% negative predictive value for MACE at
2 years (54,58). In comparison, the use of
ipyridamole MPI to predict MACE after HT is
imited to 1 study (46) that demonstrated a lower
ensitivity and negative predictive value, possibly
ecause of the longer duration of follow-up
6.5  2 years), supporting the notion that serial
tress testing, whether with DSE or MPI, is
equired to maintain high sensitivity for subse-
uent events and for better prognostication.
DCT coronary angiography and CAV. Initial studies
ith CT examined the diagnostic value of coronary
alcium scoring with electron beam tomography to
etect CAV, with conflicting results (59). MDCT
oronary angiography, however, has been shown to
ShA
1 Week 
Post-Transplant; 
EMB grade 1R
B
4 Weeks
Post-Transplant;
EMB grade 2R
C
6 Weeks 
Post-Transplant;
EMB grade 1R
Figure 5. Hyperenhancement on Cardiac Magnetic Resonance Im
(A) No hyperenhancement 1 week post-transplant. (B) Areas of hyp
ing an episode of (grade 2R) ACR. (C) Follow-up demonstrating nea
(red arrows) after treatment with intravenous steroids and enhance
resolving (grade 1R) ACR. ACR  acute cellular rejection; EMB  enetect significant coronary disease with relatively sigh sensitivities (70% to 100%) and specificities
81% to 100%) (60–66) (Table 2). MDCT offers
he advantage of evaluating the coronary lumen as
ell as the wall. This may be potentially useful
linically to allow detection, grading, and follow-up
f CAV, given that wall thickening and intimal
yperplasia are pathologic characteristics of CAV.
reliminary studies have demonstrated that changes
n vessel wall can be accurately assessed using
ongitudinal and cross-sectional images of the cor-
nary arteries to ensure adequate visualization of
he concentric grey area surrounding the contrast-
nhanced vessel lumen (63,66) (Fig. 7). Further-
ore, up to  50% of the segments considered
hickened by MDCT may be considered normal by
oronary angiography, highlighting the potential
or early CAV detection (63). There is, however, a
aucity of studies correlating changes in vessel
all by MDCT to IVUS to assess its true
 Axis                     4 Chamber  -
es in a Patient With ACR
hancement in the lateral wall and basal septum (red arrows) dur-
mplete resolution of the hyperenhancement in the lateral wall
t of immunosuppression with corresponding EMB revealing
yocardial biopsy.ort
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1134The use of MDCT does pose the technical
hallenge of reducing the heart rate enough (ideally
65 beats/min) to minimize motion artifact. As a
esult of cardiac denervation, the resting heart rate
n cardiac transplant recipients is typically elevated,
etween 80 and 110 beats/min. Pre-medication
ith beta-blockers has been associated with a de-
rease and delay in heart rate reduction. Pre-
edication with relatively high doses and increased
requency of beta-blockers have reduced the heart
ate in cardiac transplant recipients to an acceptable
evel in some studies (63,67), whereas heart rates
emained high, despite similar efforts, in another
tudy (66). A high mean heart rate during MDCT
canning can impair image quality, as reported by
ichler et al. (62) with incomplete visualization in
7% of patients (mean heart rate 87  9.7 beats/
in) mainly owing to cardiac motion. With newer
4-slice scanner technology and multisector recon-
truction algorithms, however, a heart rate of 80
eats/min may permit adequate visualization.
Despite this limitation, several studies report a
elatively high diagnostic image quality with 81% to
6% of the coronary segments defined as either of
iagnostic or satisfactory quality (60,62,63,66). A
DE-CMR*
IVUS*
Echocardiography*
(Doppler, TDI, SRI)
IVUS*
Coronary
Angiography*
MDCT*
E
D
Coro
H
Card
Induc
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Factors
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Figure 6. Different Noninvasive Imaging and Invasive Techniqu
Cardiac Allograft Vasculopathy
CE  contrast-enhanced; CMR  cardiac magnetic resonance; CMV
enhancement cardiac magnetic resonance; DSE  dobutamine stre
sound; MDCT  multidetector computed tomography; MPI  myoc
Doppler imaging.ommon reason, however, for nonevaluability of cor- anary segments relates to the small-vessel nature of
AV (60,66). The published reproducibility analysis
f MDCT (64-slice) angiography to detect significant
AV seems good with an inter-rater kappa coefficient
f 0.70 with a standard error of 0.104 (95% confidence
nterval: 0.496 to 0.905) (66). Potential limitations of
DCT scanning in cardiac transplant recipients re-
ate to the radiation and contrast media exposure
ssociated with this technique, which is especially
mportant given that chronic renal failure is frequent
n cardiac transplant recipients (1) and pre-existing
enal disease is a well-accepted risk factor for contrast-
nduced nephropathy. Preliminary studies, however,
ave demonstrated that with pre- and post-test hy-
ration and use of oral N-acetylcysteine in patients
ith normal baseline renal function, contrast-acquired
enal dysfunction is an uncommon clinical problem
60,63,66).
MR and CAV. Delayed enhancement CMR may be
seful indirectly for the detection of CAV, based on
he ability to identify areas of delayed hyperen-
ancement that likely correspond to silent myocar-
ial infarctions (68). Steen et al. (68) examined 53
ardiac transplant recipients with delayed enhance-
ent CMR performed within 4 weeks of coronary
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1135ancement with distinct subendocardial involve-
ent as “infarct typical” and likely indicative of
yocardial infarction. The prevalence of this pat-
ern increased with worsening of CAV (present in
Table 2. Studies Evaluating the Accuracy of Different Noninvasi
Author, Year (Ref. #)
Total Patients
(Prevalence of CAV)
Exer
Collings et al., 1994 (30) 51 (27%)
Mairesse et al., 1995 (31) 37 (11%)
Cohn et al., 1996 (29) 51 (51%)
Dipyrid
Ciliberto et al., 1993 (35) 80 (31%)
Ciliberto et al., 2003 (36) 68 (37%)
Dobut
Akosah et al., 1994 (33) 41 (51%)
Herregods et al., 1994 (41) 28 (50%)
Akosah et al., 1995 (69) 45 (53%)
Derumeaux et al., 1995 (37) 41 (38%)
Derumeaux et al., 1996 (38) 64 (47%)
Spes et al., 1996 (43) 46 (26%)
Akosah et al., 1998 (32) 22 (32%)
Derumeaux et al.,¶ 1998 (39) 37 (46%)
37 (70%)
Spes et al., 1999 (42) 109 (46%)
Bacal et al., 2004 (34) 39 (38%)
Eroglu et al.,# 2008 (40) 42 (19%)
Contrast-
Rodrigues et al.,** 2005 (49) 35 (29%)
Tona et al.,†† 2006 (50) 73 (47%)
Ciliberto et al., 1993 (45) 50 (30%)
Rodney et al., 1994 (55) 25 (52%)
Smart et al., 1991 (56) 73 (26%)
Ciliberto et al., 2001 (46) 78 (15%)
Carlsen et al.,  2000 (52) 67 (7%)
Elhendy et al., 2000 (53) 50 (60%)
Hacker et al., 2005 (54) 63 (17%)
M
Romeo et al., 2005 (63) 44 (14%)
Sigurdsson et al., 2006 (64) 54 (30%)
Gregory et al., 2006 (60) 20 (80%)
Pichler et al., 2008 (62) 60 (20%)
von Ziegler et al., 2008 (66) 26 (19%)
Vermes et al., 2006 (65) 50 (19%)
*In years  SD; if SD not reported, range of years is given. †Coronary stenosis 
IV. Modiﬁed mean Standford class III to IV. ¶Derumeaux et al. examined the a
conventional and quantitative stress echocardiography (post-systolic strain inde
††Tona et al. used contrast-enhanced adenosine stress echocardiography to a
narrowing. §§Cross-sectional coronary obstruction 70% on autopsy.  Carlsen
by coronary segment. ##Any abnormal wall thickening by IVUS. ***IVUS intima
CAV  cardiac allograft vasculopathy; CCA  conventional coronary angiograp
MPI  myocardial perfusion imaging; NR  not recorded.nly 25% of patients with mild CAV compared fiith 84% in patients with severe CAV). The
resence of “infarct-typical” hyperenhancement was
lso associated with worse LV function and higher
nd-diastolic and -systolic volumes. Although these
maging Techniques to Detect CAV
Time Post-HT
(yrs)* Gold Standard Sensitivity
Stress Echocardiography
4.2 (1–17) CCA† 29%
2.8 1.4 CCA‡ 0%
2.5 (1–6) CCA† (IVUS)§ 33% (15%)
ole Stress Echocardiography
2.3 .5 CCA† 100%
2.9 1.9 CCA† 100%
ne Stress Echocardiography
4.8 (0.25–10) CCA† 100%
3.2 1.3 CCA‡ 50%
4.8 0.3 CCA‡ 96%
3.3 1.7 CCA† 100%
3.3 1.2 CCA† 100%
4.8 2.6 CCA‡ (IVUS) 83% (79%)
.17 (0.04–0.33) CCA† 100%
3.1 1.7 CCA‡ 65%
4.7 1.8 CCA‡ 92%
3.2 3.1 CCA‡ and/or IVUS 72%
7.2 2.6 CCA† 64%
6.0 4.0 CCA‡‡ 75%–88%
anced Stress Echocardiography
6.0 2.6 CCA† 70%
8.0 4.5 CCA† 82%
Exercise MPI
1.7 (1–5) CCA‡ 67%
3.1 1.1 CCA‡‡ 77%
Dipyridamole MPI
2.5 1.3 CCA† or autopsy§§ 21%
2.7 1.9 CCA‡‡ 92%
5.6 (2.1–12) CCA† 80%
Dobutamine MPI
6.4 2.8 CCA† 90%
7.4 3.5 CCA† 82%
Coronary Angiography
7.6 3.8 CCA† 83%¶¶
NR CCA† (IVUS)## 94% (92%¶¶)
5.8 4.4 IVUS*** 70%¶¶
8.5 5.2 CCA††† 88%
7.7 4.1 CCA† 100%
7.7 4.0 CCA† 87%¶¶
in at least 1 vessel. ‡Any coronary obstruction including luminal irregularities. §
cy of stress echocardiography in a single group of patients at 2 different time p
ponse). **Rodrigues et al. used contrast-enhanced dobutamine stress echocardiog
s coronary ﬂow reserve. ‡‡Coronary stenosis 50% in at least 1 vessel and/or s
. study included 4 patients with bicycle exercise testing as the stressor. ¶¶Sensitiv
kness 0.5 mm. †††Coronary stenosis 70%. Modiﬁed from Thorn et al. (13).
T  heart transplantation; IVUS  intravascular ultrasound; MDCT  multidetectove I
Speciﬁcity
cise
82%
97%
85% (85%)
am
72%
87%
ami
41%
71%
52%
77%
NR
56% (83%)
0 59%
95%
73%
88%
91%
79%–88%
Enh
96%
87%
100%
100%
88%
86%
92%
55%
87%
DCT
95%¶¶
79% (95%¶¶)
92%¶¶
97%
81%
100%¶¶
50% Standford IVUS class III to
ccura oints. #Eroglu et al. used
x res raphy to assess perfusion.
sses igniﬁcant diffuse luminal
et al ity and speciﬁcity analysis
l thic
hy; H r computed tomography;ndings suggest that CMR might be useful in the
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1136etection of CAV, the clinical significance and
athologic basis of these findings are unknown.
alidation and prospective outcome-based studies
re currently underway.
onclusions
espite many advances in the field of HT, ACR,
nd CAV represent significant causes of early and
ate morbidity and mortality, respectively. Different
maging modalities, including echocardiography,
PECT-MPI, MDCT, and CMR have been used
fter HT to monitor multiple clinically important
arameters of cardiac graft structure and function.
n general, echocardiography represents the primary
oninvasive modality for monitoring cardiac func-
ion in transplant recipients based on its ability to
etect abnormalities of ventricular systolic function,
uating the Accuracy of Different Noninvasive Imaging Technique
#)
Total Patients
(Prevalence of MACE)
Time Post-HT
(yrs)*
Le
2-Dimensional Echocardiogra
5) 80 (9%) 2.3 1.5
(48) 46 (11%) NR
109 (15%) 3.2 3.1 
6) 78 (22%) 2.7 1.9
6) 68 (28%) 2.9 1.9
Dipyridamole Stress Echocard
5) 80 (9%) 2.3 0.5
6) 68 (28%) 2.9 1.9
Dobutamine Stress Echocard
) 76 (16%) 4.8 (0.25–10)
(37) 41 (5%) 3.3 1.7
) 64 (25%) 4.8 2.4
63 (56%) 4.8 2.6
) 22 (10%) 0.17 (0.04–0.33)
109 (15%) 3.2 3.1 
39 (25%) 4.0
CE-Stress Echocardiogra
66 (17%) 9.0 4.0
Dipyridamole MPI
6) 78 (22%) 2.7 1.9
Dobutamine MPI
) 77 (13%) 7.4 3.5
(58) 166 (10%) 7.4 2.5
le, range is provided. †Tona et al. used CE echocardiography to assess accuracy o
2.6). Hacker et al. compared visual¶ and semiquantitative# (summed stress sco
esting; however, both stress modalities shared similar ability to predict cardiac d
; HT  heart transplantation; MACE  major adverse cardiac event; MPI  myo
rmality.rovide estimation of right- and left-sided filling aressures with reasonable accuracy, and evaluate
ericardial effusions or other complications from
epeated biopsies.
With regard to the detection of ACR, when the
chocardiography literature is taken as a whole,
here are inconsistencies among various reports
rought about by small sample size, variability in
he reference gold standard used, and different
utoff points for the different echocardiography
arameters evaluated. Today, echocardiographic
echniques lack the sensitivity and specificity to
eplace EMBs to detect clinically significant ACR.
romising echocardiography techniques involving
DI and strain imaging are associated with rela-
ively high negative predictive values in the detec-
ion of ACR. However, further validation and
utcome-based studies are required before a specific
chocardiography parameter can be recommended
Detect MACE
h of Follow-Up
(Months)
Detection of MACE
NPVSensitivity Speciﬁcity
WMA
9.8 4.5 100% 73% 100%
45 20 40% 98% 93%
in some cases 75% 65% 94%
78 24 41% 97% 85%
72 36 80% 68% 90%
raphy
9.8 4.5 100% 71% 100%
72 36 80% 68% 90%
aphy
10 2 100% 41% 100%
6.0 100% 66% 100%
24 (18–28) 100% 69% 100%
.0 (4–14) 83% NR NR
32 11 100% 61% 100%
in some cases 94% 57% 98%
48 60% 86% 87%
19 5 86%‡ 75%‡ 97%
91%§ 62%§ 97%
78 24 53% 82% 86%
22 (12–48) 90%¶ 72%¶ 98%
90%# 88%# 98%
30 69% 71% 95%
celeration time of diastolic ﬂow velocity ‡(cutoff value 840 ms) and coronary
3) analysis. **Elhendy et al. study (65 of the 166 patients reportedly underwent
). Modiﬁed from Thorn et al. (13).
ial perfusion imaging; NPV  negative predictive value; NR  not recorded;Table 3. Studies Eval s to
Author, Year (Ref.
ngt
phy
Ciliberto et al., 1993 (3
Verhoeven et al., 1996
Spes et al., 1999 (42) 60
Ciliberto et al., 2001 (4
Ciliberto et al., 2003 (3
iog
Ciliberto et al., 1993 (3
Ciliberto et al., 2003 (3
iogr
Akosah et al., 1994 (33
Derumeaux et al., 1995
Akosah et al., 1996 (44
Lewis et al., 1997 (47) 8
Akosah et al., 1998 (32
Spes et al., 1999 (42) 60
Bacal et al., 2004 (34)
phy
Tona et al.,† 2006 (51)
Ciliberto et al., 2001 (4
Hacker et al., 2005 (54
Elhendy et al.,** 2002
*Mean  SD; if not availab f de
ﬂow reserve §(cutoff value re 
exercise not dobutamine t eath
CE  contrast enhanced cards a screening index to minimize the use of serial
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1137iopsies. CMR, similar to echocardiography, can
ccurately detect ventricular systolic dysfunction,
nd newer CMR techniques may allow the detec-
ion of myocardial edema and necrosis—hallmarks
f ACR.
In contrast, with respect to CAV, stress imaging
ith DSE and MPI and coronary angiography with
DCT are powerful techniques to identify this late
omplication with high accuracy. DSE is the most-
tudied technique with significant prognostic value
omparable to that of IVUS and invasive coronary
ngiography. For transplant centers experienced in
tress echocardiography, an invasive examination to
etect significant CAV can be reserved for patients
ith an abnormal annual DSE. Although echocar-
iography has the advantage of lower cost, the use
f MPI, especially with dobutamine, is a compara-
le alternative in cardiac transplant recipients given
ts prognostic value. MPI may be especially useful
n patients with inadequate acoustic windows de-
pite the use of a contrast echocardiography agent
nd in centers without adequate experience in DSE.
Newer CMR techniques may allow the detection
Figure 7. MDCT Coronary Angiography Demonstration of Cardi
(A) Total vessel occlusion of left anterior descending (LAD) is illustr
occlusion by MDCT volume-rendering angiography. (C) Maximum in
proximal of occlusion, an excentric noncalciﬁed plaque is depicted
changes throughout the LAD course, causing no to minimal lumina
circumﬂex; LM  left main coronary artery; MDCT  multidetector
von Ziegler et al. (66) with permission.f abnormal hyperenhancement to detect CAV Honinvasively; further pathologic and outcome
tudies, however, are needed. With the ability of
DCT coronary angiography to evaluate the cor-
nary wall in addition to the lumen, MDCT has
he potential for earlier detection of CAV compared
ith echocardiography, MPI, and CMR. This ear-
ier detection of CAV may enhance research in this
eld and prompt the early use of proliferation signal
nhibitors or other investigations to minimize CAV
isease progression and improve outcome. Further
alidation of MDCT, however, is needed in larger
tudies. Furthermore, because this technique is also
ssociated with radiation and contrast exposure, the
isk/benefit ratio needs to be concomitantly evalu-
ted, given the need for serial examinations and the
igh incidence of renal insufficiency in this patient
opulation.
eprint requests and correspondence: Dr. Jerry D. Estep,
ethodist DeBakey Heart and Vascular Center, Cardi-
logy, Smith Tower, 6550 Fannin Street, Suite 1901,
llograft Vasculopathy
by conventional coronary angiography. (B) Corresponding LAD
sity projection; grey arrows indicate site of total vessel occlusion;
cross-sectional image (note diffuse hypodense vessel wall
gularities in conventional coronary angiography). LCX  left
puted tomography; RCA  right coronary artery. Adapted fromac A
ated
ten
in a
l irre
comouston, Texas 77030. E-mail: jestep@tmhs.org.
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